Long-term recurrence of secretory breast carcinoma with metastatic sentinel lymph nodes

Archives of Gynecology and Obstetrics

Volumn 283, Issue SUPPL. 1, 2011, Pages

  Tixier, Hervé ^a,b   Picard, Anne ^a   Guiu, Séverine ^a   Coudert, Bruno ^a   Loustalot, Catherine ^a   Depret, Olivier ^c   Arnould, Laurent ^a   Cuisenier, Jean ^a  

^a Georges Francois Leclerc Anticancer Centre   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Cabinet de Pathologie   (France)

Author keywords

Metastases; Secretory breast carcinoma

Indexed keywords

RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 3; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST AREOLA; BREAST BIOPSY; BREAST CARCINOMA; BREAST HYPOPLASIA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHROMOSOME TRANSLOCATION; ECHOMAMMOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAMMOGRAPHY; METASTASIS POTENTIAL; PARTIAL MASTECTOMY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SECRETORY BREAST CARCINOMA; SENTINEL LYMPH NODE;

ADULT; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 79956107417     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1669-9     Document Type: Article

References (12)

1. Nogales F, Tavassoli FA (2003) Pathology and genetics of tumors of the breast and female genital organs. IARC Press, Lyon
2. McDivitt RW, Stewart FW (1966) Breast carcinoma in children. JAMA 195(5):388-390
3. Vieni S, Cabibi D, Cipolla C, Fricano S, Graceffa G, Latteri MA (2006) Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol 4:88
4. Jacquemier J (2009) Diagnostic pitfalls in mammary pathology. Case 5. Secretory carcinoma. Ann Pathol 29(3):211-215
5. Lannon CL, Sorensen PH (2005) ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 15(3):215-223
6. Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI et al (2007) ETV6- NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 12(6):542-558 (Pubitemid 350199073)
7. Makretsov N, He M, Hayes M, Chia S, Horsman DE, Sorensen PH et al (2004) A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer 40(2):152-157 (Pubitemid 38579884)
8. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA et al (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2(5):367-376 (Pubitemid 41039103)
9. Lae M, Freneaux P, Sastre-Garau X, Chouchane O, Sigal-Zafrani B, Vincent-Salomon A (2009) Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basallike carcinoma spectrum. Mod Pathol 22(2):291-298
10. Fadare O, Tavassoli FA (2008) Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol 5(3):149-159
11. Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG (1989) Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology 14(1):25-36 (Pubitemid 19045805)
12. Iglesias B, Monteagudo B, Rouco JS, Anton I (2009) Secretory breast carcinoma in a 63-year-old man. J Cutan Pathol 36(Suppl 1):86-88